US Stock MarketDetailed Quotes

CANNAPHARMARX INC (CPMD)

Watchlist
  • 0.0040
  • 0.00000.00%
15min DelayClose Apr 6 14:07 ET
2.71MMarket Cap-0.20P/E (TTM)

CANNAPHARMARX INC (CPMD) Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
53.51%-789.1K
690.05%1.06M
-48.40%-802.7K
-4.41%-446.46K
-9.58%-601.38K
25.38%-1.7M
86.21%-179.89K
-536.64%-540.9K
11.31%-427.62K
10.28%-548.83K
Net income from continuing operations
-12.37%-11.13M
-101.82%-7.55M
-884.31%-1.48M
-126.36%-1.41M
94.11%-690.59K
-368.56%-9.91M
-149.58%-3.74M
133.39%188.42K
385.29%5.36M
-729.38%-11.72M
Operating gains losses
33.85%783.9K
187.03%1.46M
-1,360.94%-78.38K
100.64%46.44K
-108.72%-641.71K
108.82%585.65K
107.29%507.81K
101.36%6.22K
-1,254.26%-7.29M
4,672.68%7.36M
Depreciation and amortization
----
----
--0
--0
--0
--0
9.14%-87.28K
--0
952.38%64.24K
295.49%23.04K
Other non cash items
-49.38%2.89M
-126.63%-1M
9.79%693.57K
-10.39%657.52K
341.61%2.55M
343.23%5.71M
3,052.69%3.77M
-37.27%631.74K
--733.72K
254.96%576.42K
Change In working capital
1,685.95%431.5K
1,721.19%1.33M
-89.81%-231.82K
-77.02%-257.2K
-289.45%-413.61K
102.94%24.16K
104.13%73.26K
-3.42%-122.13K
-120.33%-145.29K
-38.40%218.33K
-Change in receivables
-2,589.46%-1.02M
-277.07%-442.94K
-130,779.56%-473.78K
185.48%158.22K
-1,016.86%-263.92K
207.31%41.07K
3,571.36%250.15K
97.13%-362
-1,425.46%-185.08K
-272.60%-23.63K
-Change in inventory
-291.31%-1.99M
-747.23%-697.36K
-399.16%-285.48K
-11.61%-588.9K
-1,243.76%-416.31K
55.19%-508.05K
109.50%107.75K
---57.19K
---527.62K
---30.98K
-Change in prepaid assets
----
----
----
----
----
--0
--0
--0
--0
--0
-Change in payables and accrued expense
547.76%3.18M
33,643.50%2.21M
484.22%527.45K
78.14%239.64K
-26.55%200.46K
77.76%491.14K
98.95%-6.6K
237.72%90.28K
-78.03%134.52K
-24.35%272.94K
-Change in other current assets
----
----
----
----
----
--0
--0
--0
--0
--0
-Change in other working capital
--260.56K
----
----
----
--66.15K
----
----
-292.63%-154.86K
----
----
Cash from discontinued investing activities
Operating cash flow
53.51%-789.1K
690.05%1.06M
-48.40%-802.7K
-4.41%-446.46K
-9.58%-601.38K
25.38%-1.7M
86.21%-179.89K
-536.64%-540.9K
11.31%-427.62K
10.28%-548.83K
Investing cash flow
Cash flow from continuing investing activities
-5.52K
0
0
0
0
0
Net PPE purchase and sale
---5.52K
----
----
----
----
--0
--0
--0
--0
--0
Cash from discontinued investing activities
Investing cash flow
---5.52K
----
----
----
----
--0
--0
--0
--0
--0
Financing cash flow
Cash flow from continuing financing activities
-53.24%794.27K
-702.72%-1.06M
46.01%786.65K
8.85%462.23K
7.17%600.43K
-27.82%1.7M
-86.61%175.05K
481.26%538.75K
-7.80%424.67K
13.57%560.27K
Net issuance payments of debt
-53.24%794.27K
-501.44%-1.06M
46.01%786.65K
8.85%462.23K
27.07%600.43K
-27.82%1.7M
-79.89%262.82K
481.26%538.75K
-7.80%424.67K
-4.22%472.5K
Proceeds from stock option exercised by employees
----
----
--0
--0
--0
----
----
--0
--0
--87.77K
Cash from discontinued financing activities
Financing cash flow
-53.24%794.27K
-702.72%-1.06M
46.01%786.65K
8.85%462.23K
7.17%600.43K
-27.82%1.7M
-86.61%175.05K
481.26%538.75K
-7.80%424.67K
13.57%560.27K
Net cash flow
Beginning cash position
231.69%2.16K
-86.76%927
85.62%16.98K
-90.01%1.21K
231.69%2.16K
-71.95%650
--7K
--9.15K
--12.09K
-71.95%650
Current changes in cash
-123.37%-352
118.11%877
-647.81%-16.05K
634.84%15.77K
-108.28%-948
190.34%1.51K
-845.08%-4.84K
-101.01%-2.15K
96.91%-2.95K
109.59%11.44K
Effect of exchange rate changes
----
----
----
----
----
--0
--0
--0
--0
--0
End cash Position
-16.33%1.8K
-16.33%1.8K
-86.76%927
85.62%16.98K
-90.01%1.21K
231.69%2.16K
231.69%2.16K
--7K
--9.15K
--12.09K
Free cash flow
53.18%-794.62K
686.98%1.06M
-48.40%-802.7K
-4.41%-446.46K
-9.58%-601.38K
27.93%-1.7M
86.23%-179.89K
-551.88%-540.9K
23.09%-427.62K
10.41%-548.83K
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit Opinions
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 53.51%-789.1K690.05%1.06M-48.40%-802.7K-4.41%-446.46K-9.58%-601.38K25.38%-1.7M86.21%-179.89K-536.64%-540.9K11.31%-427.62K10.28%-548.83K
Net income from continuing operations -12.37%-11.13M-101.82%-7.55M-884.31%-1.48M-126.36%-1.41M94.11%-690.59K-368.56%-9.91M-149.58%-3.74M133.39%188.42K385.29%5.36M-729.38%-11.72M
Operating gains losses 33.85%783.9K187.03%1.46M-1,360.94%-78.38K100.64%46.44K-108.72%-641.71K108.82%585.65K107.29%507.81K101.36%6.22K-1,254.26%-7.29M4,672.68%7.36M
Depreciation and amortization ----------0--0--0--09.14%-87.28K--0952.38%64.24K295.49%23.04K
Other non cash items -49.38%2.89M-126.63%-1M9.79%693.57K-10.39%657.52K341.61%2.55M343.23%5.71M3,052.69%3.77M-37.27%631.74K--733.72K254.96%576.42K
Change In working capital 1,685.95%431.5K1,721.19%1.33M-89.81%-231.82K-77.02%-257.2K-289.45%-413.61K102.94%24.16K104.13%73.26K-3.42%-122.13K-120.33%-145.29K-38.40%218.33K
-Change in receivables -2,589.46%-1.02M-277.07%-442.94K-130,779.56%-473.78K185.48%158.22K-1,016.86%-263.92K207.31%41.07K3,571.36%250.15K97.13%-362-1,425.46%-185.08K-272.60%-23.63K
-Change in inventory -291.31%-1.99M-747.23%-697.36K-399.16%-285.48K-11.61%-588.9K-1,243.76%-416.31K55.19%-508.05K109.50%107.75K---57.19K---527.62K---30.98K
-Change in prepaid assets ----------------------0--0--0--0--0
-Change in payables and accrued expense 547.76%3.18M33,643.50%2.21M484.22%527.45K78.14%239.64K-26.55%200.46K77.76%491.14K98.95%-6.6K237.72%90.28K-78.03%134.52K-24.35%272.94K
-Change in other current assets ----------------------0--0--0--0--0
-Change in other working capital --260.56K--------------66.15K---------292.63%-154.86K--------
Cash from discontinued investing activities
Operating cash flow 53.51%-789.1K690.05%1.06M-48.40%-802.7K-4.41%-446.46K-9.58%-601.38K25.38%-1.7M86.21%-179.89K-536.64%-540.9K11.31%-427.62K10.28%-548.83K
Investing cash flow
Cash flow from continuing investing activities -5.52K00000
Net PPE purchase and sale ---5.52K------------------0--0--0--0--0
Cash from discontinued investing activities
Investing cash flow ---5.52K------------------0--0--0--0--0
Financing cash flow
Cash flow from continuing financing activities -53.24%794.27K-702.72%-1.06M46.01%786.65K8.85%462.23K7.17%600.43K-27.82%1.7M-86.61%175.05K481.26%538.75K-7.80%424.67K13.57%560.27K
Net issuance payments of debt -53.24%794.27K-501.44%-1.06M46.01%786.65K8.85%462.23K27.07%600.43K-27.82%1.7M-79.89%262.82K481.26%538.75K-7.80%424.67K-4.22%472.5K
Proceeds from stock option exercised by employees ----------0--0--0----------0--0--87.77K
Cash from discontinued financing activities
Financing cash flow -53.24%794.27K-702.72%-1.06M46.01%786.65K8.85%462.23K7.17%600.43K-27.82%1.7M-86.61%175.05K481.26%538.75K-7.80%424.67K13.57%560.27K
Net cash flow
Beginning cash position 231.69%2.16K-86.76%92785.62%16.98K-90.01%1.21K231.69%2.16K-71.95%650--7K--9.15K--12.09K-71.95%650
Current changes in cash -123.37%-352118.11%877-647.81%-16.05K634.84%15.77K-108.28%-948190.34%1.51K-845.08%-4.84K-101.01%-2.15K96.91%-2.95K109.59%11.44K
Effect of exchange rate changes ----------------------0--0--0--0--0
End cash Position -16.33%1.8K-16.33%1.8K-86.76%92785.62%16.98K-90.01%1.21K231.69%2.16K231.69%2.16K--7K--9.15K--12.09K
Free cash flow 53.18%-794.62K686.98%1.06M-48.40%-802.7K-4.41%-446.46K-9.58%-601.38K27.93%-1.7M86.23%-179.89K-551.88%-540.9K23.09%-427.62K10.41%-548.83K
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Audit Opinions Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes--------
Market Insights
China Concept Stocks
View More
Middle East conflict spreads to the stock market! How should investors respond?
The US-Iran situation has reached a major turning point as Trump announced a two-week suspension of military actions against Iran, with both Show More